pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-361 |
Genomic Coordinates | chrX: 85903636 - 85903707 |
Synonyms | MIRN361, hsa-mir-361, MIR361 |
Description | Homo sapiens miR-361 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-361-5p | |||||||||||||||||||||
Sequence | 6| UUAUCAGAAUCUCCAGGGGUAC |27 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DUSP3 | ||||||||||||||||||||
Synonyms | VHR | ||||||||||||||||||||
Description | dual specificity phosphatase 3 | ||||||||||||||||||||
Transcript | NM_004090 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DUSP3 | |||||||||||||||||||||
3'UTR of DUSP3 (miRNA target sites are highlighted) |
>DUSP3|NM_004090|3'UTR 1 GGCACCCCCACCACCTCTGCTCGAGAGGTCCGTGGGGGAGGCCGTGGGCAAAGGTGTCCCGAGCTGCCATGTTTAGGAAA 81 CACACTGTACCCTGCTCCCAGCATCACAAGGCACTTGTCTACAAGTGTGTCCCAACACAGTCCTGGGCCACTTTCCCCAC 161 CCTGGGGAGCACATAAAGAAGCTTGCCAAGGGGGGCGTCCTTGCTCCCCAGTTGTCCTGTTTCTGTAACTTATGATGTCT 241 TTTCCCTGAGATGGGGGCTCAGAGGGGGAAGGCCTGTGGCCTGCATGCTTCCCGATGGCCCACGGCAGGAGGTGTGTGGA 321 AGTGTAAGGCCTAAGATGCTCACAGAGGTCCCTCATGACCTCCCTTCCCCAACTCCCGAATCCTCTCTTGAGTGTGGACC 401 TCAACACCTTGAGCCCTAGTAAAGGAACTATGCAAATGCAGGCCACTCTCCCCACCACGTCTGTGCCCTGCACTGTCCCC 481 ACAGCCTTCCACACCCTGTGCATAGGCAGCCCTCTCACGTCTTGAGGTCCGAAGCTGGGGTGGGGGTGTCCGTCAGTTAT 561 TAGTGGATGGAGATTCCCACAGCAAGGCTGCATTTGAATGATTTCCTTAGGATGAATGGTCCCTACACAAAGAGGCCTTG 641 TGGGCAAACCTGGAGAACCCTCCTAAATCCATAGAGTTTTCAAAATGTGAATCTTTGGAAGCCTTGAGTTCAGAATCTGC 721 TGCTCTGGAATATTTCCCTTCGATCTTATCTCAGTCACTTCGTTTTTGAGAAGAGTGATGCCTTGGGCATGCTTTTTTTT 801 TTTTCTTTTTTAGAAAACAGGGAGTTGAAGTCCAACCTATTTAAAAACCCCACCATTTGGAGAATTACAAGGGTTTTGTC 881 CTGAATTGTAGTGTTGGCAAGCCCAAGCCACTCGTGCTAACTGCTTTTTGTCTCGGTTGCTATTCCAAGAACAGAAGGAG 961 GAAGTTGGCCAATTACAGCGTGTGTGCATGGATGTGTGTGGGGGGCGTGCCTCTCAGAAACGCGGCCAGAAGACAAGCAG 1041 GGAAGTGAAAGGTCCCAGGCACACACCCTGCCCATTGCAGGTGGCTCTTACAGCTCTCTGGTGCCAGCACGGGATCCCTG 1121 AAGTGACTCAGCCAGGCAGACATGAGACATGGCGGAGTGTCCAAATGGATCCTTTATTGGTGGTAGAGCAAAAAAACCCA 1201 AACACGATAAACCTTTCAAAAGACTTTCTAAGGATGATATTGGAATGCACCAGCCCTCACATGTGTATGCACATTTGCCA 1281 GAATATAAGAGTTTTGTTTTAAATACAGTCTTGTTAGGATTTTACGTTATTGTTATTATGGAAAGTGATTGTGATGCTAT 1361 TTATCTTCAGGGTCACTCTGGGCAAAGAGAAGGTCCTCAGCCATGCCCCCAGCACCTTGCACATAGGTGTCTGATAAAAG 1441 TTTAAGAAAGTAAACACTTTTTGAGCACCAAATATATATAGGGCATTGTTCTGGTGGGTGTGTCACGCTCCCAGAAGACT 1521 GAATTCATGGTAGGATCACTCGCAAGGCCTTGTGAAGGAGTCTTACCTAAAACGAAAGAAATATCAGGGACTTTTGTTGA 1601 CTATTTACAACTCAGTTTTACATTTAAATTCAGGCAGTGTTAATATGCCAAGGTAGGGAATGTGCCTTTTTCAGAGTTGG 1681 CCAGGAGCTCCTGGCTGGGACACGGAGAGGCAGGTGTGGCGTAAGGCCTCACTCCCGGCTGGGAAGGTCTCTGATCACAC 1761 AGAAGCAGCCCTGCCCAGCCTGGTCATTTGCTGTCCGCTTTTCTCTGTGACCACAGCAGCCCTGAACAACCAGTATGTGT 1841 CTTCTTCTCCAGATAGTGAAAAAGGTGTCCAGATAAACCCACCTAAGTGAAATGGCCATCCTCTAAACTGGGTACCTCAC 1921 TGCACAGCTTCTAGGTAGCCTTCCAACTTAATCTAACTTGAGCCTCACAGTAACCCTGTAAAGTTAGTAGAGCTTGTTCT 2001 TGTATTGTGACCTTTTTTAAAAAAAAGGAACTGAGGTTCAGAATGATTAAGGGCCTGGCCCCCAGGGTTGTCCAGCTCCA 2081 TAAGGTGGAGCTGGGCAAGATTTTGGGTTTGCTGCTCCCTGAAGCTGGATTCTTTCATACGATACTCTTTCTCAAGAAGG 2161 GGGCTCCCTGGGATCTCCAGGTGTACTGCACTTACCCTCAATCCAGCCCCGGAGAAGCAAGTGAAAAGGGTGGGTCCCTC 2241 ATAGGCTAGAATGTGCAGCTCTTTCTCCAGGTGGGATGTAGCACCCCGAAGTAGAGCTTTCTGCTCTGCTCCTGGAAAAG 2321 GCTAGGGAGCTGGGGCTGGGGCTCCCCTCCCATGACCAGGCAGTGGTCACCCCATGGGACAGGCACAGCTACTTACGCGA 2401 ACACAGCAGGTTGGTGTGGCTGGCTAACTAGGACCTCTCGAAAGTCTCTGTGGGGGCATGAGGGAGAAAAGGCCATTGGG 2481 AGAATTACTGCCTTTACTTTGGGACTACTTTTATGCTGATAACTTGGGATTTCTTGATAGTCCTTCACCCCTGAAACCCC 2561 GTATTTACTTAACAAGATTTAGCTCTTAGTTCTTCAAGTAAAATTAAAGTCTCTTGTGTAAGAGCCAACACATGCCCAGC 2641 TGCGGATGGGAGCTGTTCCTGGACAGCCTTCTACTGCCTGGGAAGTGATGGAACAGGAACTCAGGGTGCCCTTACCCCCT 2721 CCCCAGACCTGTTCCCTTTCTTTGACTGACAGAGCACCATCCAGGCAAAATTAGAGCGCCAAATGGTTTTCTTCTCAATC 2801 TTAAAGCAGTATACCTTTCCACAGGCTCGTCTGTGTCCCTGCCACTCTGAGTTATCCAGAAACCACCACCTACAAATGAG 2881 GGGACTCATCTAGAAGACCTCTAAGGTCCCCTTTTGGCTCTGAGGGGTCTCTAATAATCCCCACTTGGAATTCAGCACCG 2961 CAAGGAAATTATGGGTATGTGAGCCATAATATGATGGGCAGCAGGTGGCGCTGCCTTCCACCCATGGTGATGGATGGTTT 3041 GGAAAGGGAATGTTGGTGCCTTTTGTGCCACAAGTTAAGATGCTACTGTTTTAAAGGAAAAAAAAAAAAAAAAGTACTGA 3121 TCTTCAATATGAAGACATGAGCTTTTCTCGCAGGAAATTTTCTTTTTCACAGAACTGGTGTCAGGAATCACTGAAGGGCT 3201 AACCGTGATAGTCCTTGCAAGTAAGTCAAGGTTTTATCCTGATTGGAAATAGAAGACATTTCCGGTTGAGAGAACAGATT 3281 CGTTGGAAGCTTAACTTTTGTTGCCTCTTAACGCCACCAAATTTTAGGGTAATTTGATTATGAAAGAGTGAATTTTTCTG 3361 GACAGAAAAGGGAGAGCTACCAAATTGTTTTTTTCTTTTTAAAAGGAAGTTTAATGTCCGTTGTATCACAAATCAGTGTT 3441 AAAACACCAGAACTTTAGCCAAAATAAATGTCTTACATTACAAAGGTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 1845.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_004090 | 3UTR | UUAUGCUGAUAACUUGGGAUUUCUUGAUAGUCCUUCACCCCUGAAACCCCGUAUUUACUUAACAAGAUUUAGCUCUUAGUUCUUCAAGUAAAAUUAAAGUCUCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_004090 | 3UTR | CUGAUAACUUGGGAUUUCUUGAUAGUCCUUCACCCCUGAAACCCCGUAUUUACUUAACAAGAUUUAGCUCUUAGUUCUUCAAGUAAAAUUAAAGUCUCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_004090 | 3UTR | GGUGUCUGAUAAAAGUUUAAGAAAGUAAACACUUUUUGAGCACCAAAUAUAUAUAGGGCAUUGUUCUGGUGGGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_004090 | 3UTR | AAGGUCCUCAGCCAUGCCCCCAGCACCUUGCACAUAGGUGUCUGAUAAAAGUUUAAGAAAGUAAACACUUUUUGAGCACCAAAUAUAUAUAGGGCAUUGUUCUGGUGGGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_004090 | 3UTR | UUACUUUGGGACUACUUUUAUGCUGAUAACUUGGGAUUUCUUGAUAGUCCUUCACCCCUGAAACCCCGUAUUUACUUAACAAGAUUUAGCUCUUAGUUCUUCAAGUAAAAUUAAAGUCUCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000226004.3 | 3UTR | ACUACUUUUAUGCUGAUAACUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
152 hsa-miR-361-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT004447 | VEGFA | vascular endothelial growth factor A | 4 | 3 | ||||||||
MIRT020074 | U2SURP | U2 snRNP associated SURP domain containing | 1 | 1 | ||||||||
MIRT020075 | RPUSD4 | RNA pseudouridylate synthase domain containing 4 | 1 | 1 | ||||||||
MIRT020076 | DEPDC1B | DEP domain containing 1B | 1 | 1 | ||||||||
MIRT020077 | CENPQ | centromere protein Q | 1 | 1 | ||||||||
MIRT020078 | EAPP | E2F associated phosphoprotein | 1 | 1 | ||||||||
MIRT020079 | CD46 | CD46 molecule | 1 | 1 | ||||||||
MIRT020080 | EDC3 | enhancer of mRNA decapping 3 | 1 | 1 | ||||||||
MIRT020081 | LHFPL4 | LHFPL tetraspan subfamily member 4 | 1 | 1 | ||||||||
MIRT020082 | ZNF92 | zinc finger protein 92 | 1 | 1 | ||||||||
MIRT020083 | ZNF776 | zinc finger protein 776 | 1 | 1 | ||||||||
MIRT020084 | ARF4 | ADP ribosylation factor 4 | 1 | 1 | ||||||||
MIRT020085 | WDR36 | WD repeat domain 36 | 1 | 1 | ||||||||
MIRT020086 | ZMYND11 | zinc finger MYND-type containing 11 | 1 | 1 | ||||||||
MIRT020087 | FGFR1OP2 | FGFR1 oncogene partner 2 | 1 | 1 | ||||||||
MIRT020088 | RAB8B | RAB8B, member RAS oncogene family | 1 | 1 | ||||||||
MIRT020089 | TNRC6A | trinucleotide repeat containing 6A | 1 | 1 | ||||||||
MIRT020090 | CEBPG | CCAAT/enhancer binding protein gamma | 1 | 1 | ||||||||
MIRT020091 | KLHL28 | kelch like family member 28 | 1 | 1 | ||||||||
MIRT020092 | G3BP2 | G3BP stress granule assembly factor 2 | 1 | 1 | ||||||||
MIRT020093 | SRSF3 | serine and arginine rich splicing factor 3 | 2 | 3 | ||||||||
MIRT020094 | RNF141 | ring finger protein 141 | 1 | 1 | ||||||||
MIRT020095 | YOD1 | YOD1 deubiquitinase | 1 | 1 | ||||||||
MIRT020096 | DUSP3 | dual specificity phosphatase 3 | 2 | 3 | ||||||||
MIRT020097 | NCEH1 | neutral cholesterol ester hydrolase 1 | 1 | 1 | ||||||||
MIRT020098 | GTF2E1 | general transcription factor IIE subunit 1 | 1 | 1 | ||||||||
MIRT020099 | PHACTR4 | phosphatase and actin regulator 4 | 1 | 1 | ||||||||
MIRT020100 | ZC3H12C | zinc finger CCCH-type containing 12C | 1 | 1 | ||||||||
MIRT020101 | ARCN1 | archain 1 | 1 | 1 | ||||||||
MIRT020102 | RNF4 | ring finger protein 4 | 1 | 1 | ||||||||
MIRT020103 | CPOX | coproporphyrinogen oxidase | 1 | 1 | ||||||||
MIRT020104 | CDC123 | cell division cycle 123 | 1 | 1 | ||||||||
MIRT044053 | SLC30A5 | solute carrier family 30 member 5 | 1 | 1 | ||||||||
MIRT044054 | ATP6V1A | ATPase H+ transporting V1 subunit A | 1 | 1 | ||||||||
MIRT044055 | TMEM62 | transmembrane protein 62 | 1 | 1 | ||||||||
MIRT044056 | ZNF554 | zinc finger protein 554 | 1 | 1 | ||||||||
MIRT044057 | MAGEF1 | MAGE family member F1 | 1 | 1 | ||||||||
MIRT044058 | GRK6 | G protein-coupled receptor kinase 6 | 1 | 1 | ||||||||
MIRT044059 | DDX23 | DEAD-box helicase 23 | 1 | 1 | ||||||||
MIRT044060 | BSG | basigin (Ok blood group) | 1 | 1 | ||||||||
MIRT044061 | VCPIP1 | valosin containing protein interacting protein 1 | 1 | 1 | ||||||||
MIRT044062 | VCP | valosin containing protein | 1 | 1 | ||||||||
MIRT044063 | PTCD3 | pentatricopeptide repeat domain 3 | 1 | 1 | ||||||||
MIRT044064 | SLC25A5 | solute carrier family 25 member 5 | 1 | 1 | ||||||||
MIRT044065 | ZNF207 | zinc finger protein 207 | 1 | 1 | ||||||||
MIRT044066 | EGFL7 | EGF like domain multiple 7 | 1 | 1 | ||||||||
MIRT044067 | SETD1A | SET domain containing 1A | 1 | 1 | ||||||||
MIRT044068 | KIAA1549L | KIAA1549 like | 1 | 1 | ||||||||
MIRT044069 | COX1 | cytochrome c oxidase subunit I | 1 | 1 | ||||||||
MIRT044070 | SON | SON DNA binding protein | 1 | 1 | ||||||||
MIRT044071 | HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT044072 | PPA1 | pyrophosphatase (inorganic) 1 | 1 | 1 | ||||||||
MIRT044073 | DCTN1 | dynactin subunit 1 | 1 | 1 | ||||||||
MIRT044074 | ERAL1 | Era like 12S mitochondrial rRNA chaperone 1 | 1 | 1 | ||||||||
MIRT044075 | CYCS | cytochrome c, somatic | 1 | 1 | ||||||||
MIRT044076 | ACTG1 | actin gamma 1 | 1 | 1 | ||||||||
MIRT044077 | RANBP17 | RAN binding protein 17 | 1 | 1 | ||||||||
MIRT044078 | QTRTD1 | queuine tRNA-ribosyltransferase accessory subunit 2 | 1 | 1 | ||||||||
MIRT044079 | NCOA6 | nuclear receptor coactivator 6 | 1 | 1 | ||||||||
MIRT044080 | ACLY | ATP citrate lyase | 1 | 1 | ||||||||
MIRT044081 | LNPEP | leucyl and cystinyl aminopeptidase | 1 | 1 | ||||||||
MIRT044082 | C14orf80 | tubulin epsilon and delta complex 1 | 1 | 1 | ||||||||
MIRT044083 | VBP1 | VHL binding protein 1 | 1 | 1 | ||||||||
MIRT044084 | OGDH | oxoglutarate dehydrogenase | 1 | 1 | ||||||||
MIRT044085 | ASH1L | ASH1 like histone lysine methyltransferase | 1 | 1 | ||||||||
MIRT044086 | MDC1 | mediator of DNA damage checkpoint 1 | 1 | 1 | ||||||||
MIRT044087 | RPS2 | ribosomal protein S2 | 1 | 1 | ||||||||
MIRT044088 | UCK2 | uridine-cytidine kinase 2 | 1 | 1 | ||||||||
MIRT044089 | PRPF8 | pre-mRNA processing factor 8 | 1 | 1 | ||||||||
MIRT044090 | GSPT1 | G1 to S phase transition 1 | 1 | 1 | ||||||||
MIRT044091 | CALCOCO2 | calcium binding and coiled-coil domain 2 | 1 | 1 | ||||||||
MIRT044092 | USP22 | ubiquitin specific peptidase 22 | 1 | 1 | ||||||||
MIRT044093 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 1 | 1 | ||||||||
MIRT044094 | CNOT2 | CCR4-NOT transcription complex subunit 2 | 1 | 1 | ||||||||
MIRT044095 | SMG1 | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | 1 | 1 | ||||||||
MIRT044096 | WBP2 | WW domain binding protein 2 | 1 | 1 | ||||||||
MIRT044097 | ZBTB33 | zinc finger and BTB domain containing 33 | 1 | 1 | ||||||||
MIRT044098 | GPC6 | glypican 6 | 1 | 1 | ||||||||
MIRT044099 | PRKCSH | protein kinase C substrate 80K-H | 1 | 1 | ||||||||
MIRT044100 | EIF3C | eukaryotic translation initiation factor 3 subunit C | 1 | 1 | ||||||||
MIRT044101 | SUPT16H | SPT16 homolog, facilitates chromatin remodeling subunit | 1 | 1 | ||||||||
MIRT044102 | DOCK6 | dedicator of cytokinesis 6 | 1 | 1 | ||||||||
MIRT044103 | ECD | ecdysoneless cell cycle regulator | 1 | 1 | ||||||||
MIRT044104 | EPHA4 | EPH receptor A4 | 1 | 1 | ||||||||
MIRT044105 | EIF4A1 | eukaryotic translation initiation factor 4A1 | 1 | 1 | ||||||||
MIRT044106 | PSMD2 | proteasome 26S subunit, non-ATPase 2 | 1 | 1 | ||||||||
MIRT044107 | RAE1 | ribonucleic acid export 1 | 1 | 1 | ||||||||
MIRT044108 | RAVER1 | ribonucleoprotein, PTB binding 1 | 1 | 1 | ||||||||
MIRT044109 | TP53BP1 | tumor protein p53 binding protein 1 | 1 | 1 | ||||||||
MIRT044110 | COPS7A | COP9 signalosome subunit 7A | 1 | 1 | ||||||||
MIRT044111 | GTDC2 | protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | 1 | 1 | ||||||||
MIRT044112 | CDK2 | cyclin dependent kinase 2 | 1 | 1 | ||||||||
MIRT044113 | NOP2 | NOP2 nucleolar protein | 1 | 1 | ||||||||
MIRT112226 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT127737 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 2 | 2 | ||||||||
MIRT226898 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | 2 | 2 | ||||||||
MIRT235959 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT241215 | MTPAP | mitochondrial poly(A) polymerase | 2 | 4 | ||||||||
MIRT243416 | ZMAT3 | zinc finger matrin-type 3 | 2 | 2 | ||||||||
MIRT294566 | ZNF460 | zinc finger protein 460 | 2 | 4 | ||||||||
MIRT321041 | RAC1 | Rac family small GTPase 1 | 2 | 4 | ||||||||
MIRT437351 | STAT6 | signal transducer and activator of transcription 6 | 3 | 1 | ||||||||
MIRT438339 | SND1 | staphylococcal nuclease and tudor domain containing 1 | 3 | 1 | ||||||||
MIRT444521 | WWTR1 | WW domain containing transcription regulator 1 | 2 | 2 | ||||||||
MIRT447699 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT464962 | TWIST1 | twist family bHLH transcription factor 1 | 2 | 2 | ||||||||
MIRT468193 | SGK1 | serum/glucocorticoid regulated kinase 1 | 2 | 2 | ||||||||
MIRT473767 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT482630 | AAR2 | AAR2 splicing factor homolog | 2 | 2 | ||||||||
MIRT484150 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT490457 | PROSER2 | proline and serine rich 2 | 2 | 2 | ||||||||
MIRT493066 | MTCH1 | mitochondrial carrier 1 | 2 | 2 | ||||||||
MIRT493579 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 8 | ||||||||
MIRT506495 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT514833 | ZNF154 | zinc finger protein 154 | 2 | 6 | ||||||||
MIRT519028 | KYNU | kynureninase | 2 | 6 | ||||||||
MIRT521750 | PPIL1 | peptidylprolyl isomerase like 1 | 2 | 4 | ||||||||
MIRT522899 | KCNJ3 | potassium voltage-gated channel subfamily J member 3 | 2 | 4 | ||||||||
MIRT527368 | MGARP | mitochondria localized glutamic acid rich protein | 2 | 2 | ||||||||
MIRT530684 | C8orf46 | chromosome 8 open reading frame 46 | 2 | 2 | ||||||||
MIRT531397 | TMEM18 | transmembrane protein 18 | 2 | 2 | ||||||||
MIRT533163 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT534579 | RPL28 | ribosomal protein L28 | 2 | 2 | ||||||||
MIRT545955 | ZBTB10 | zinc finger and BTB domain containing 10 | 2 | 2 | ||||||||
MIRT553282 | TSR1 | TSR1, ribosome maturation factor | 2 | 2 | ||||||||
MIRT553531 | TMEM185B | transmembrane protein 185B | 2 | 4 | ||||||||
MIRT555601 | PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | 2 | 2 | ||||||||
MIRT556005 | NAPG | NSF attachment protein gamma | 2 | 2 | ||||||||
MIRT556738 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT556971 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT558904 | CCDC58 | coiled-coil domain containing 58 | 2 | 2 | ||||||||
MIRT559220 | BLMH | bleomycin hydrolase | 2 | 2 | ||||||||
MIRT559821 | SLPI | secretory leukocyte peptidase inhibitor | 2 | 2 | ||||||||
MIRT562671 | AKT3 | AKT serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT564793 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT564827 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT570505 | TFIP11 | tuftelin interacting protein 11 | 2 | 2 | ||||||||
MIRT571381 | JKAMP | JNK1/MAPK8-associated membrane protein | 2 | 2 | ||||||||
MIRT572562 | AFF1 | AF4/FMR2 family member 1 | 2 | 2 | ||||||||
MIRT610398 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT641614 | DEFB118 | defensin beta 118 | 2 | 2 | ||||||||
MIRT642143 | CHORDC1 | cysteine and histidine rich domain containing 1 | 2 | 2 | ||||||||
MIRT643846 | EPGN | epithelial mitogen | 2 | 4 | ||||||||
MIRT651751 | VEGFB | vascular endothelial growth factor B | 2 | 2 | ||||||||
MIRT657353 | HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 2 | 2 | ||||||||
MIRT662436 | RALGAPA1 | Ral GTPase activating protein catalytic alpha subunit 1 | 2 | 2 | ||||||||
MIRT700990 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT707393 | DCAF4L1 | DDB1 and CUL4 associated factor 4 like 1 | 2 | 2 | ||||||||
MIRT712064 | XRCC5 | X-ray repair cross complementing 5 | 2 | 2 | ||||||||
MIRT721145 | PLCL1 | phospholipase C like 1 (inactive) | 2 | 2 | ||||||||
MIRT724466 | SMAD2 | SMAD family member 2 | 2 | 2 | ||||||||
MIRT731374 | CXCR6 | C-X-C motif chemokine receptor 6 | 1 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|